Market Overview:
The global dermatology diagnostic devices and therapeutics market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of skin diseases, rising awareness about skin health, and technological advancements in dermatology diagnostic devices. Based on type, the global dermatology diagnostic devices and therapeutics market is segmented into dermoscopes, microscopes, trichoscopes, imaging equipment, antibacterial agents, antifungal agents, antiviral agents corticosteroids retinoids immunosuppressants. Dermoscopes are expected to account for the largest share of the global dermatology diagnostic devices and therapeutics market in 2018 owing to their high usage rates for diagnosing various skin conditions.
Product Definition:
Dermatology Diagnostic Devices and Therapeutics are devices and therapies used to diagnose and treat skin conditions. They are important because they allow doctors to identify and treat skin conditions accurately.
Dermatoscopes:
Dermatoscopes are used for skin examination and diagnosis. It is a handheld device that allows the dermatologist to view various parts of the body such as scalp, neck, back, and face in order to diagnose skin diseases or injuries. The dermatoscope consists of two light sources: one source illuminates the target area while other directed towards it for observation purposes.
Microscopes:
Microscopes are instruments that help in magnification and examination of objects. It is a two-dimensional optical device that aids in viewing the object with greater clarity. Microscopes can be categorized into optical microscopes, electron microscopes, scanning probe microscopy and others (ultrasound, X-ray).
The global dermatology diagnostics devices & therapeutics market size was valued at USD 5.6 billion in 2016.
Application Insights:
The others segment held the largest share of the market in 2017. This includes dermatology centers and other outpatient facilities. These facilities provide a wide range of dermatology services, such as diagnosis and treatment of skin cancer, acne & rosacea, eczema & psoriasis, wrinkles & lines, sun damage/age spots/hyperpigmentation along with aesthetic procedures like botox and fillers. The growth in this segment can be attributed to an increase in demand for non-invasive procedures that do not require hospitalization or surgery for treatment along with an increase in the adoption of these devices by individuals seeking cosmetic treatments at home.
The hospitals application segment is anticipated to witness lucrative growth over the forecast period due to factors such as increasing prevalence of chronic diseases that require longterm medical management along with rising awareness regarding early detection through regular checkups by patients themselves.
Regional Analysis:
North America dominated the global market in 2017. The presence of well-established healthcare infrastructure, high adoption rate of advanced technologies, and increasing prevalence of skin diseases due to increased exposure to environmental factors are some major drivers responsible for regional growth. Moreover, an increase in R&D investment by companies is expected to drive the market over the forecast period. For instance, In April 2018; BMG Pharma invested USD X million for new drug development program over a period of 5 years focusing on psoriasis treatment with its lead product candidate BMP 2 mg film-coated tablets DERmodURso PsOtic (bupropion hydrochloride).
Asia Pacific is anticipated to be one of the fastest growing regions during the forecast period owing to rising disposable income and improving healthcare infrastructure especially in developing countries such as India and China. Growing medical tourism industry due to low cost associated with various treatments will also contribute towards regional growth during the estimated time frame.
Growth Factors:
- Increasing incidence of skin diseases: The global dermatology diagnostic devices and therapeutics market is expected to grow at a CAGR of 6.5% from 2016 to 2021, owing to the increasing incidence of skin diseases such as psoriasis, acne, and eczema.
- Growing demand for minimally invasive procedures: The demand for minimally invasive procedures is growing due to their advantages over traditional surgical procedures such as shorter recovery time and reduced pain and scarring. This is driving the growth of the dermatology diagnostic devices market.
- Rising awareness about skin health: There is an increasing awareness among people about the importance of skin health and its impact on overall health and well-being. This is leading to an increase in the number of people seeking treatment for various skin conditions, thereby driving the growth of the dermatology diagnostics market.
Scope Of The Report
Report Attributes
Report Details
Report Title
Dermatology Diagnostic Devices and Therapeutics Market Research Report
By Type
Dermatoscopes, Microscopes, Trichoscopes, Imaging Equipment, Antibacterial Agents, Antifungal Agents, Antiviral Agents, Corticosteroids, Retinoids, Immunosuppressants
By Application
Hospitals, Clinics, Others
By Companies
Agfa, Astellas Pharma, Cutera, Dino-Lite, Galderma, Genentech, Stiefel, LEO Pharma, Michelson Diagnostics, Novartis, Agfa, Canfield Scientific
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
205
Number of Tables & Figures
144
Customization Available
Yes, the report can be customized as per your need.
Global Dermatology Diagnostic Devices and Therapeutics Market Report Segments:
The global Dermatology Diagnostic Devices and Therapeutics market is segmented on the basis of:
Types
Dermatoscopes, Microscopes, Trichoscopes, Imaging Equipment, Antibacterial Agents, Antifungal Agents, Antiviral Agents, Corticosteroids, Retinoids, Immunosuppressants
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Agfa
- Astellas Pharma
- Cutera
- Dino-Lite
- Galderma
- Genentech
- Stiefel
- LEO Pharma
- Michelson Diagnostics
- Novartis
- Agfa
- Canfield Scientific
Highlights of The Dermatology Diagnostic Devices and Therapeutics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Dermatoscopes
- Microscopes
- Trichoscopes
- Imaging Equipment
- Antibacterial Agents
- Antifungal Agents
- Antiviral Agents
- Corticosteroids
- Retinoids
- Immunosuppressants
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Dermatology Diagnostic Devices and Therapeutics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Dermatology diagnostic devices and therapeutics are medical devices and treatments used to diagnose, treat, or prevent skin diseases.
Some of the major companies in the dermatology diagnostic devices and therapeutics market are Agfa, Astellas Pharma, Cutera, Dino-Lite, Galderma, Genentech, Stiefel, LEO Pharma, Michelson Diagnostics, Novartis, Agfa, Canfield Scientific.
The dermatology diagnostic devices and therapeutics market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Dermatology Diagnostic Devices and Therapeutics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Dermatology Diagnostic Devices and Therapeutics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Dermatology Diagnostic Devices and Therapeutics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Dermatology Diagnostic Devices and Therapeutics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Dermatology Diagnostic Devices and Therapeutics Market Size & Forecast, 2020-2028
4.5.1 Dermatology Diagnostic Devices and Therapeutics Market Size and Y-o-Y Growth
4.5.2 Dermatology Diagnostic Devices and Therapeutics Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Dermatoscopes
5.2.2 Microscopes
5.2.3 Trichoscopes
5.2.4 Imaging Equipment
5.2.5 Antibacterial Agents
5.2.6 Antifungal Agents
5.2.7 Antiviral Agents
5.2.8 Corticosteroids
5.2.9 Retinoids
5.2.10 Immunosuppressants
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Dermatology Diagnostic Devices and Therapeutics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Dermatology Diagnostic Devices and Therapeutics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Dermatoscopes
9.6.2 Microscopes
9.6.3 Trichoscopes
9.6.4 Imaging Equipment
9.6.5 Antibacterial Agents
9.6.6 Antifungal Agents
9.6.7 Antiviral Agents
9.6.8 Corticosteroids
9.6.9 Retinoids
9.6.10 Immunosuppressants
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Dermatoscopes
10.6.2 Microscopes
10.6.3 Trichoscopes
10.6.4 Imaging Equipment
10.6.5 Antibacterial Agents
10.6.6 Antifungal Agents
10.6.7 Antiviral Agents
10.6.8 Corticosteroids
10.6.9 Retinoids
10.6.10 Immunosuppressants
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Dermatoscopes
11.6.2 Microscopes
11.6.3 Trichoscopes
11.6.4 Imaging Equipment
11.6.5 Antibacterial Agents
11.6.6 Antifungal Agents
11.6.7 Antiviral Agents
11.6.8 Corticosteroids
11.6.9 Retinoids
11.6.10 Immunosuppressants
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Dermatoscopes
12.6.2 Microscopes
12.6.3 Trichoscopes
12.6.4 Imaging Equipment
12.6.5 Antibacterial Agents
12.6.6 Antifungal Agents
12.6.7 Antiviral Agents
12.6.8 Corticosteroids
12.6.9 Retinoids
12.6.10 Immunosuppressants
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Dermatoscopes
13.6.2 Microscopes
13.6.3 Trichoscopes
13.6.4 Imaging Equipment
13.6.5 Antibacterial Agents
13.6.6 Antifungal Agents
13.6.7 Antiviral Agents
13.6.8 Corticosteroids
13.6.9 Retinoids
13.6.10 Immunosuppressants
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Dermatology Diagnostic Devices and Therapeutics Market: Competitive Dashboard
14.2 Global Dermatology Diagnostic Devices and Therapeutics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Agfa
14.3.2 Astellas Pharma
14.3.3 Cutera
14.3.4 Dino-Lite
14.3.5 Galderma
14.3.6 Genentech
14.3.7 Stiefel
14.3.8 LEO Pharma
14.3.9 Michelson Diagnostics
14.3.10 Novartis
14.3.11 Agfa
14.3.12 Canfield Scientific
